Thursday, January 1, 2026 1/1/2026

Investigation of neural ensembles underlying chronic pain

Award Number: F30DA056215
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 11/12/2022
PERIOD OF PERFORMANCE END DATE: 11/11/2026

Group Awards By:

View Award Description

Investigation of neural ensembles underlying chronic pain - PROJECT SUMMARY Chronic pain affects nearly 1 in every 5 adults worldwide 1, posing a major public health concern and economic burden. Yet, despite the widespread prevalence of chronic pain, few effective strategies for long-term pain management exist. Historically, physicians have relied upon a cocktail of analgesics, including tricyclic antidepressants, serotonin norepinephrine reuptake inhibitors, and opiates, to treat persistent symptoms in chronic pain patients 54. However, this approach carries significant risks – reliance upon prescription opioids has fueled the opioid abuse epidemic that has crippled the United States for the past two decades, and long- term use of opioids has conversely been shown to increase pain sensitivity over time, necessitating larger and larger doses to achieve analgesic efficacy 53. Therefore, to successfully combat the opioid epidemic, we must investigate underlying mechanisms of pain chronification in pursuit of novel, non-addictive pain interventions. Until recently, much of the pain field has focused on peripheral nervous system and spinal cord circuit dysfunction, which primarily influence the somatosensory elements of chronic pain. Chronic pain, however, is more than purely a sensory phenomenon; patients also suffer from the “unpleasantness” or negative valence associated with pain 22. Recent work from our collaborators has identified a specific ensemble of neurons within the basolateral amygdala (BLA) that encodes for the negative valence of pain 22. However, it remains unknown how activity within these nociceptive BLA neurons and the circuits in which they are embedded are altered post-injury, and whether these changes contribute to pain chronification. Using an innovative activity-based rabies screen pioneered by our lab 28 in parallel with an unbiased whole-brain c-Fos activity mapping approach, we can generate a list of input regions to the BLA whose activity is elevated exclusively during chronic pain. To test the functional contribution of these input circuits in pain chronification, we will perform chemogenetic inhibition studies in tandem with classical pain assays. By identifying brain-wide, circuit-level changes that occur post-injury to promote chronic pain, we will elucidate key brain regions and circuit targets that will enable the development of non-opiate therapies for mitigating chronic pain.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $54,538 )
2026	2026	UNIVERSITY OF CALIFORNIA IRVINE	160 ALDRICH HALL	IRVINE	CA	92697	ORANGE	USA	Drug Use and Addiction Research Programs	000	4	12/18/2025	NON-COMPETING CONTINUATION	$54,538
														Subtotal = $54,538

Issue Date FY: 2025 ( Subtotal = $54,538 )
2025	2025	UNIVERSITY OF CALIFORNIA IRVINE	160 ALDRICH HALL	IRVINE	CA	92697	ORANGE	USA	Drug Use and Addiction Research Programs	001	3	7/22/2025	NON-COMPETING CONTINUATION	$564
2025	2025	UNIVERSITY OF CALIFORNIA IRVINE	160 ALDRICH HALL	IRVINE	CA	92697	ORANGE	USA	Drug Use and Addiction Research Programs	000	3	10/31/2024	NON-COMPETING CONTINUATION	$53,974
														Subtotal = $54,538

Issue Date FY: 2024 ( Subtotal = $40,988 )
2024	2024	UNIVERSITY OF CALIFORNIA IRVINE	160 ALDRICH HALL	IRVINE	CA	92697	ORANGE	USA	Drug Use and Addiction Research Programs	001	2	11/7/2023	NON-COMPETING CONTINUATION	$39,708
2024	2024	UNIVERSITY OF CALIFORNIA IRVINE	160 ALDRICH HALL	IRVINE	CA	92697	ORANGE	USA	Drug Use and Addiction Research Programs	002	2	5/1/2024	NON-COMPETING CONTINUATION	$1,280
2024	2022	UNIVERSITY OF CALIFORNIA IRVINE	160 ALDRICH HALL	IRVINE	CA	92697	ORANGE	USA	Drug Use and Addiction Research Programs	000	1	11/6/2023	NEW	$0
														Subtotal = $40,988

Issue Date FY: 2022 ( Subtotal = $38,766 )
2022	2022	UNIVERSITY OF CALIFORNIA, IRVINE	141 INNOVATION DR STE 250	IRVINE	CA	92617	ORANGE	USA	Drug Use and Addiction Research Programs	001	1	5/24/2022	NEW	-$1
2022	2022	UNIVERSITY OF CALIFORNIA, IRVINE	141 INNOVATION DR STE 250	IRVINE	CA	92617	ORANGE	USA	Drug Use and Addiction Research Programs	002	1	5/24/2022	NEW	$0
2022	2022	UNIVERSITY OF CALIFORNIA, IRVINE	141 INNOVATION DR STE 250	IRVINE	CA	92617	ORANGE	USA	Drug Use and Addiction Research Programs	000	1	5/17/2022	NEW	$38,767
														Subtotal = $38,766

Grand Total All Awards = $188,830

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Investigation of neural ensembles underlying chronic pain

Award Number: F30DA056215

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 11/12/2022

PERIOD OF PERFORMANCE END DATE: 11/11/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer